SAR428926 / ImmunoGen, AbbVie, Sanofi  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SAR428926 / Sanofi
NCT02575781: A Study of SAR428926 in Patients With Advanced Solid Tumors

Completed
1
34
Europe
SAR428926
Sanofi
Neoplasm Malignant
06/18
06/18

Download Options